IGF-1 LR3 for Bodybuilding
IGF-1 LR3 is the most potent anabolic peptide researched for bodybuilding applications. Its modified structure reduces IGFBP binding by ~500x, producing a 20–30 hour half-life vs 12 minutes for native IGF-1. Post-workout injection activates mTOR, drives satellite cell proliferation, and maximizes nutrient partitioning — directing amino acids and glucose toward muscle protein synthesis.
Why IGF-1 LR3 Works for Bodybuilding
IGF-1 LR3 binds the IGF-1 receptor and activates PI3K → Akt → mTOR — the master regulator of muscle protein synthesis. This directly drives the anabolic response to resistance training, amplifying the gains from each session.
Activates muscle satellite cells (myogenic stem cells), promoting their proliferation and fusion into existing muscle fibers. This is the mechanism behind potential hyperplasia (new fiber formation) in addition to hypertrophy.
Increases GLUT4 translocation and glucose uptake in muscle tissue, directing post-workout carbohydrates toward glycogen synthesis and muscle protein synthesis rather than fat storage.
Intramuscular injection into the trained muscle groups concentrates IGF-1 LR3 activity locally, theoretically directing the anabolic signal to the specific muscles just trained — the rationale for bilateral IM injection protocols.
IGF-1 LR3 Bodybuilding Dosage Protocol
| Phase | Dose | Timing | Notes |
|---|---|---|---|
| Beginner (Weeks 1–2) | 20–40mcg/day | Post-workout SubQ | Assess hypoglycemia tolerance; have 20–30g fast carbs available |
| Intermediate (Weeks 1–6) | 50–80mcg/day | Post-workout SubQ or bilateral IM | Primary bodybuilding protocol; strong nutrient partitioning effect |
| Advanced (Weeks 1–6) | 80–100mcg/day | Post-workout bilateral IM | Maximum research dose; significantly elevated hypoglycemia risk |
| Off cycle | None | 4–6 weeks | Allow IGF-1 receptor sensitivity to reset before next cycle |
IGF-1 LR3 vs CJC-1295 vs Ipamorelin for Bodybuilding
| Factor | IGF-1 LR3 | CJC-1295 | Ipamorelin |
|---|---|---|---|
| Primary mechanism | mTOR activation, satellite cell proliferation | GH/IGF-1 elevation via pituitary | Clean GH pulse, no cortisol/prolactin |
| Anabolic potency | High (direct receptor activation) | Moderate (indirect via GH) | Moderate (indirect via GH) |
| Hypoglycemia risk | Yes — significant | Low | Low |
| Cycle length | 4–6 weeks (desensitization) | 12+ weeks | 12+ weeks |
| Best timing | Post-workout | Pre-sleep | Pre-sleep |
| Body recomposition | Strong | Strong (long-term) | Moderate |
| Stack together? | Yes (separate cycle from CJC/Ipa) | Yes + Ipamorelin | Yes + CJC-1295 |
Hypoglycemia Management Protocol
Always inject post-workout, never fasted
Have 20–30g fast-acting carbohydrates immediately available (glucose tablets, juice, candy)
Start at 20mcg and assess tolerance for 3–5 days before increasing
If dizziness, sweating, or shakiness occurs — consume fast carbs immediately and sit down
Do not drive or operate machinery for 1–2 hours post-injection
Monitor blood glucose if diabetic or pre-diabetic — IGF-1 LR3 is contraindicated
IGF-1 LR3 from Purgo Labs
≥99% purity, third-party COA verified, cGMP facility.
Use code HEALTH for 15% off.
Shop IGF-1 LR3Frequently Asked Questions
What is the best IGF-1 LR3 dosage for bodybuilding?
The most commonly researched bodybuilding protocol is 50–100mcg per day, injected post-workout subcutaneously or intramuscularly into the trained muscle groups. Beginners should start at 20–40mcg to assess hypoglycemia tolerance. The 50–80mcg range is the sweet spot for most intermediate users — strong anabolic effect with manageable hypoglycemia risk. Doses above 100mcg/day significantly increase risk without proportional benefit.
Should bodybuilders inject IGF-1 LR3 intramuscularly or subcutaneously?
Both work, but intramuscular (IM) injection into the trained muscle groups is preferred by many bodybuilders for the theoretical local anabolic effect — directing IGF-1 activity to the muscles just trained. Subcutaneous (SubQ) injection in the abdomen produces systemic distribution. For bilateral muscle groups (chest, legs), bilateral IM injections split the dose between both sides. SubQ is simpler and still effective for systemic body composition benefits.
When should bodybuilders take IGF-1 LR3?
Post-workout injection is the standard timing for bodybuilding applications — the anabolic window immediately after training maximizes nutrient partitioning and mTOR activation. Always inject with post-workout nutrition (protein + carbohydrates) available to prevent hypoglycemia. Some advanced users also use a second injection on rest days in the morning, but this increases hypoglycemia risk and is not standard.
How long should bodybuilders cycle IGF-1 LR3?
4–6 week cycles with equal time off is the standard recommendation. IGF-1 receptor downregulation (desensitization) occurs with continuous use beyond 6 weeks, significantly reducing effectiveness. The off-cycle period allows receptor sensitivity to reset. Many bodybuilders time IGF-1 LR3 cycles to coincide with the most intensive training blocks of their periodization program.
What results can bodybuilders expect from IGF-1 LR3?
Typical results from a 4–6 week cycle at 50–100mcg/day include: improved muscle fullness and pumps (from increased nutrient partitioning), faster recovery between sessions, and modest lean mass gains (1–3 lbs over the cycle). IGF-1 LR3 is not a mass-building compound in the same category as anabolic steroids — its primary value is enhanced nutrient partitioning, recovery quality, and satellite cell activation that compounds over multiple cycles.
Can IGF-1 LR3 cause hypoglycemia in bodybuilders?
Yes — hypoglycemia is the primary risk. IGF-1 has insulin-like activity and can cause blood glucose to drop. Always inject post-workout with carbohydrate-containing nutrition immediately available. Never inject in a fasted state. Symptoms include dizziness, sweating, shakiness, and confusion. If symptoms occur, consume fast-acting carbohydrates (glucose tablets, juice, candy) immediately. Start at 20mcg and assess tolerance before increasing.